Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease. (Q36193854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

3

Sandra E Black

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Pearl Behl

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Taresa L Stefurak

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

140-151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

Episodic and semantic memory: a comparison of amnesic and demented patients

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Visualisation and quantification of rates of atrophy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Correlation between rates of brain atrophy and cognitive decline in AD.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Testing correlation of cognitive decline at adjacent stages of dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A functional decline model for prevalent cohort data

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A three-factor model of cognition in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The Test for Severe Impairment: An Instrument for the Assessment of Patients with Severe Cognitive Dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Some morphometric aspects of the brain in senile dementia of the alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Early detection of Alzheimer's disease using the Cambridge Cognitive Examination (CAMCOG).

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Symptom progression in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The Diagnosis of Dementia in the Elderly a Comparison of CAMCOG (the Cognitive Section of CAMDEX), the AGECAT Program, DSM–III, the Mini-Mental State Examination and Some Short Rating Scales

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Validation of the Full and Short Forms of the CAMDEX Interview for Diagnosing Dementia: Evidence from a One-Year Follow-Up Study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A comparison of the category fluency deficits associated with Alzheimer's and Huntington's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type: a double cross-validation and application to a community-dwelling sample

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Dementia: characteristics of a referral population and factors associated with progression.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Rate of progression and prognostic factors in Alzheimer's disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Severe impairment battery. A neuropsychological test for severely demented patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Defining meaningful change in Alzheimer's disease trials: the donepezil experience

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Characteristics of elderly who develop Alzheimer's disease during the next two years-a neuropsychological study using CAMCOG. The Odense Study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A method for estimating progression rates in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Alzheimer's disease: a correlational analysis of the Blessed Information-Memory-Concentration Test and the Mini-Mental State Exam.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Progression and outcome of patients in a Canadian dementia clinic.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Observations on the short-term 'natural history' of probable Alzheimer's disease in a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neuropsychological subgroups of dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Necropsy evidence of central cholinergic deficits in senile dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Prognosis of Alzheimer's disease: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Update on diagnostic methods, natural history and outcome variables in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Rate of progression of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A longitudinal population study of the mini-mental state examination in the very old: relation to dementia and education

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Some psychometric properties of the CAMCOG.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The treatment of Alzheimer's disease: success short of cure

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Cognitive test performance in detecting, staging, and tracking Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Current diagnostic methods and outcome variables for clinical investigation of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Measuring cognitive change in a cohort of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Monitoring Progression in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Longitudinal cognitive, electroencephalographic and morphological brain changes in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Cognitive deterioration in Alzheimer's disease: behavioral and health factors.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Predictors of mortality in patients diagnosed with probable Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Anatomic and physiologic imaging of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neuropathology of Alzheimer's disease: what is new since A. Alzheimer?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Population-based studies of AD: message and methods: an epidemiologic view.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Patterns of deterioration in senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The diagnosis of dementia with single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Psychometric considerations when measuring cognitive decline in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Mild senile dementia of the Alzheimer type: 3. Longitudinal and cross-sectional assessment

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Progression of cognitive impairment in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Natural history of Alzheimer's disease: prognostic value of plateaux

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Hearing impairment and cognitive decline in senile dementia of the Alzheimer's type

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Progressive decline in NART score with increasing dementia severity

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

https://api.crossref.org/works/10.1017%2FS0317167100003917

1 reference

7 January 2021

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Reliability of cognitive tests used in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Population-based norms for the Mini-Mental State Examination by age and educational level

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A new clinical scale for the staging of dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Rating scales in old age psychiatry

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The rate of progression of Alzheimer's disease in the later stages: evidence from the Severe Impairment Battery.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Predictors of cognitive decline in the early stage of probable Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Longitudinal change in three brief assessments of SDAT.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Taking account of between-patient variability when modeling decline in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Measurement of progression in Alzheimer's disease: a clinician's perspective

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The clinical diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

Correlations of Mini-Mental State and modified Dementia Rating Scale to measures of transitional health status in dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003917

7 January 2021

10.1017/S0317167100003917

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16018149%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference